These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 7826075

  • 1. [Neuroblastoma].
    Sawada T, Komatsu H, Shirai C, Yamamoto S, Ishiwari K, Ishida H, Ohmizono Y, Matsumura T.
    Gan To Kagaku Ryoho; 1995 Jan; 22(1):28-36. PubMed ID: 7826075
    [Abstract] [Full Text] [Related]

  • 2. Improved survival for patients with advanced neuroblastoma after high-dose combined chemotherapy based in part on N-myc amplification.
    Suita S, Tajiri T, Sera Y, Takamatsu H, Mizote H, Nagasaki A, Kurosaki N, Hara T, Okamura J, Miyazaki S, Sugimoto T, Kawakami K, Eguchi H, Tsuneyoshi M.
    J Pediatr Surg; 2000 Dec; 35(12):1737-41. PubMed ID: 11101726
    [Abstract] [Full Text] [Related]

  • 3. Trk mRNA and low affinity nerve growth factor receptor mRNA expression and triploid DNA content in favorable neuroblastoma tumors.
    Kogner P, Barbany G, Björk O, Castello MA, Donfrancesco A, Falkmer UG, Hedborg F, Kouvidou H, Persson H, Raschella G.
    Prog Clin Biol Res; 1994 Dec; 385():137-45. PubMed ID: 7972205
    [Abstract] [Full Text] [Related]

  • 4. Coexpression of messenger RNA for TRK protooncogene and low affinity nerve growth factor receptor in neuroblastoma with favorable prognosis.
    Kogner P, Barbany G, Dominici C, Castello MA, Raschellá G, Persson H.
    Cancer Res; 1993 May 01; 53(9):2044-50. PubMed ID: 8481906
    [Abstract] [Full Text] [Related]

  • 5. Favorable prognosis for patients 12 to 18 months of age with stage 4 nonamplified MYCN neuroblastoma: a Children's Cancer Group Study.
    Schmidt ML, Lal A, Seeger RC, Maris JM, Shimada H, O'Leary M, Gerbing RB, Matthay KK.
    J Clin Oncol; 2005 Sep 20; 23(27):6474-80. PubMed ID: 16116154
    [Abstract] [Full Text] [Related]

  • 6. Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma.
    Nakagawara A, Arima-Nakagawara M, Scavarda NJ, Azar CG, Cantor AB, Brodeur GM.
    N Engl J Med; 1993 Mar 25; 328(12):847-54. PubMed ID: 8441429
    [Abstract] [Full Text] [Related]

  • 7. Hyperdiploidy plus nonamplified MYCN confers a favorable prognosis in children 12 to 18 months old with disseminated neuroblastoma: a Pediatric Oncology Group study.
    George RE, London WB, Cohn SL, Maris JM, Kretschmar C, Diller L, Brodeur GM, Castleberry RP, Look AT.
    J Clin Oncol; 2005 Sep 20; 23(27):6466-73. PubMed ID: 16116152
    [Abstract] [Full Text] [Related]

  • 8. [Management strategy in neuroblastoma].
    Balwierz W.
    Przegl Lek; 2004 Sep 20; 61 Suppl 2():3-8. PubMed ID: 15686038
    [Abstract] [Full Text] [Related]

  • 9. Prognostic factors in metastatic neuroblastoma in patients over 1 year of age treated with high-dose chemotherapy and stem cell transplantation: a multivariate analysis in 218 patients treated in a single institution.
    Hartmann O, Valteau-Couanet D, Vassal G, Lapierre V, Brugières L, Delgado R, Couanet D, Lumbroso J, Benhamou E.
    Bone Marrow Transplant; 1999 Apr 20; 23(8):789-95. PubMed ID: 10231141
    [Abstract] [Full Text] [Related]

  • 10. High-dose chemotherapy followed by locoregional irradiation improves the outcome of patients with international neuroblastoma staging system Stage II and III neuroblastoma with MYCN amplification.
    Laprie A, Michon J, Hartmann O, Munzer C, Leclair MD, Coze C, Valteau-Couanet D, Plantaz D, Carrie C, Habrand JL, Bergeron C, Chastagner P, Défachelles AS, Delattre O, Combaret V, Bénard J, Pérel Y, Gandemer V, Rubie H, Neuroblastoma Study Group of the French Society of Pediatric Oncology.
    Cancer; 2004 Sep 01; 101(5):1081-9. PubMed ID: 15329919
    [Abstract] [Full Text] [Related]

  • 11. MYCN protein expression as a predictor of neuroblastoma prognosis.
    Chan HS, Gallie BL, DeBoer G, Haddad G, Ikegaki N, Dimitroulakos J, Yeger H, Ling V.
    Clin Cancer Res; 1997 Oct 01; 3(10):1699-706. PubMed ID: 9815553
    [Abstract] [Full Text] [Related]

  • 12. Lack of correlation of N-myc gene amplification with prognosis in localized neuroblastoma: a Pediatric Oncology Group study.
    Cohn SL, Look AT, Joshi VV, Holbrook T, Salwen H, Chagnovich D, Chesler L, Rowe ST, Valentine MB, Komuro H.
    Cancer Res; 1995 Feb 15; 55(4):721-6. PubMed ID: 7850780
    [Abstract] [Full Text] [Related]

  • 13. Inverse correlation between N-myc amplification and catecholamine metabolism in children with advanced neuroblastoma.
    Nakagawara A, Ikeda K, Higashi K, Sasazuki T.
    Surgery; 1990 Jan 15; 107(1):43-9. PubMed ID: 2404349
    [Abstract] [Full Text] [Related]

  • 14. Prognostic significance of circulating tumor cells and bone marrow micrometastasis in advanced neuroblastoma.
    Kuroda T, Morikawa N, Matsuoka K, Fujino A, Honna T, Nakagawa A, Kumagai M, Masaki H, Saeki M.
    J Pediatr Surg; 2008 Dec 15; 43(12):2182-5. PubMed ID: 19040931
    [Abstract] [Full Text] [Related]

  • 15. Prognostic significance of DNA di-tetraploidy in neuroblastoma.
    Ladenstein R, Ambros IM, Pötschger U, Amann G, Urban C, Fink FM, Schmitt K, Jones R, Slociak M, Schilling F, Ritter J, Berthold F, Gadner H, Ambros PF.
    Med Pediatr Oncol; 2001 Jan 15; 36(1):83-92. PubMed ID: 11464912
    [Abstract] [Full Text] [Related]

  • 16. Expression of the apoptosis-suppressing protein bcl-2, in neuroblastoma is associated with unfavorable histology and N-myc amplification.
    Castle VP, Heidelberger KP, Bromberg J, Ou X, Dole M, Nuñez G.
    Am J Pathol; 1993 Dec 15; 143(6):1543-50. PubMed ID: 8256847
    [Abstract] [Full Text] [Related]

  • 17. [Evaluation of efficacy of treatment for 30 children with neuroblastoma].
    Sun XF, Liu DG, Su YS, Lin TY, Chen XQ, He YJ.
    Ai Zheng; 2003 Dec 15; 22(12):1343-5. PubMed ID: 14693065
    [Abstract] [Full Text] [Related]

  • 18. [Can intensive induction chemotherapy eradicate retroperitoneal lymph node metastases in children over 1 year of age with stage 4 neuroblastoma?].
    Niezgoda A, Balwierz W, Bysiek A, Miezyński W, Klekawka T, Garus K.
    Przegl Lek; 2004 Dec 15; 61 Suppl 2():9-13. PubMed ID: 15686039
    [Abstract] [Full Text] [Related]

  • 19. N7: a novel multi-modality therapy of high risk neuroblastoma (NB) in children diagnosed over 1 year of age.
    Cheung NK, Kushner BH, LaQuaglia M, Kramer K, Gollamudi S, Heller G, Gerald W, Yeh S, Finn R, Larson SM, Wuest D, Byrnes M, Dantis E, Mora J, Cheung IY, Rosenfield N, Abramson S, O'Reilly RJ.
    Med Pediatr Oncol; 2001 Jan 15; 36(1):227-30. PubMed ID: 11464891
    [Abstract] [Full Text] [Related]

  • 20. Neuroblastoma.
    Meir HM, Balawi I, Nayel H, Yousef MK, Badawood S, Al-Mobarak M.
    Saudi Med J; 2001 Aug 15; 22(8):674-80. PubMed ID: 11573111
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.